What are the differences between biphasic and monophasic defibrillation waveforms and their recommended initial energy settings (joules) for adult cardiac arrest?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Biphasic vs Monophasic Defibrillation: Key Differences and Energy Settings

Biphasic defibrillators are superior to monophasic defibrillators and should be used preferentially, with initial energy settings of 120-200 J for biphasic waveforms compared to 360 J for monophasic waveforms. 1

Fundamental Waveform Differences

Monophasic waveforms deliver electrical current in only one direction (single polarity), with two main subtypes 1:

  • Monophasic damped sinusoidal (MDS): Current gradually returns to zero
  • Monophasic truncated exponential (MTE): Current abruptly returns to zero

Biphasic waveforms deliver current that reverses direction, flowing in two phases, and are now used in almost all modern AEDs and manual defibrillators 1. Few monophasic defibrillators are currently being manufactured, though many remain in clinical use 1.

Clinical Efficacy: Why Biphasic is Superior

First-Shock Success Rates

Biphasic waveforms achieve dramatically higher first-shock efficacy:

  • Biphasic: 85-98% success rate at ≤200 J, with one study showing 90% first-shock success 2, 1
  • Monophasic: Lower success rates requiring higher energies 1

At equivalent 200 J energy levels, biphasic shocks reduced the risk of post-shock asystole or persistent VF by 81% compared to monophasic shocks (RR 0.19; 95% CI 0.06-0.60) 3.

Energy Efficiency

Biphasic waveforms achieve equal or superior defibrillation at significantly lower energies 1:

  • Biphasic shocks at 115-130 J are as effective as monophasic shocks at 200 J 3
  • At very low energies (70-100 J), biphasic waveforms show marked superiority: at 70 J, biphasic achieved 80% success vs. 32% for monophasic 4
  • Lower energy delivery results in less myocardial injury as measured by ST segment changes 3

Recommended Initial Energy Settings

For Biphasic Defibrillators (Preferred)

Use manufacturer-recommended dose, typically:

  • 150-200 J for biphasic truncated exponential waveforms 1
  • 120 J for rectilinear biphasic waveforms 1
  • If manufacturer's recommendation unknown, 200 J is reasonable for initial shock 1, 2

For Monophasic Defibrillators (Legacy Devices)

Use 360 J for initial and all subsequent shocks 1. This simplified approach recognizes that most EMS systems may still have monophasic devices in service 1.

Subsequent Shocks

  • Biphasic: Use same or higher energy; optimal escalation strategy not definitively established 1
  • Monophasic: Continue with 360 J 1
  • No evidence of harm from biphasic energies up to 360 J in human studies 1

Critical Clinical Context

Survival Outcomes

Important caveat: While biphasic waveforms show superior shock success (defined as VF termination for ≥5 seconds), no specific waveform has been consistently associated with higher rates of ROSC or survival to hospital discharge 1. This emphasizes that defibrillation is only one component of successful resuscitation—high-quality CPR and minimizing interruptions in chest compressions remain paramount 1.

Modern Resuscitation Protocol

The high first-shock efficacy of biphasic defibrillators (>90%) has fundamentally changed resuscitation protocols 1:

  • Single-shock strategy followed by immediate CPR is now recommended, replacing the older 3-stacked-shock sequence 1
  • Resume CPR immediately after shock delivery without pulse/rhythm check 1
  • The 3-shock sequence created unacceptable 29-37 second delays in chest compressions 1

Common Pitfalls to Avoid

  1. Don't assume all defibrillators at the same energy setting deliver identical energy: Actual delivered energy can deviate by +23% to -29% from selected settings 5

  2. Don't delay defibrillation searching for "optimal" energy: Use manufacturer's recommended dose or 200 J biphasic/360 J monophasic and proceed immediately 1, 2

  3. Don't confuse shock success with patient survival: VF termination doesn't guarantee ROSC or survival—continue high-quality CPR regardless of waveform type 1

  4. Don't use synchronized mode for VF: This applies to both waveform types and can result in failure to deliver shock 6

Bottom Line for Clinical Practice

Biphasic defibrillators should be the standard of care due to their superior first-shock efficacy, lower energy requirements, and reduced myocardial injury 1, 2, 3. When using biphasic devices, start with 120-200 J (or manufacturer's recommendation); when using legacy monophasic devices, use 360 J 1. Most importantly, minimize interruptions in chest compressions and deliver shocks as part of an integrated, high-quality resuscitation effort 1.

Related Questions

What is the difference between biphasic and monophasic shocks in cardiac arrest management?
What is the difference between monophasic and biphasic defibrillators?
What is the recommended joules (energy level) protocol for three stacked shocks in a Cardiac Arrest Life Support (CALS) scenario?
What is the initial shock dose in joules for cardiac arrest?
What is the treatment for persistent ventricular fibrillation?
Is it safe for a patient to alternate Uzedy (paliperidone palmitate) 250 mg every two months with Aristada (aripiprazole lauroxil) 1064 mg every two months on a monthly schedule?
Can you explain the left knee X‑ray findings, including tibial spiking and the absence of fracture, in simple terms for a family member?
What are the differential diagnoses for hypercalcemia with acute kidney injury and a suppressed parathyroid hormone level?
In a 71-year-old woman with chronic heart failure and chronic respiratory failure, does Symbicort (budesonide + formoterol) cause tachycardia or raise blood glucose?
Based on the RENOVATE trial, should high‑flow nasal oxygen be initiated as first‑line therapy in adult emergency department patients with acute hypoxemic respiratory failure (significant hypoxemia, tachypnea, moderate ARDS) including non‑immunocompromised, immunocompromised, COPD exacerbation, acute cardiogenic pulmonary edema, or COVID‑19 pneumonia, and what are the recommended settings, monitoring, and escalation criteria?
What is the next recommended pharmacologic treatment for an ADHD patient who has already trialed lisdexamfetamine 50 milligrams and methylphenidate (Foquest) 85 milligrams without adequate response?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.